Femasys Inc (FEMY): Shareholders' Equity

Annual figures by period end, from SEC filings.

$5.87M
As of 2025-12-31
$4.03M
As of 2026-06-30
-27.2%
3-year compound annual growth
$26.33M2020-12-31: -$51.82M2021-12-31: $26.33M2022-12-31: $15.24M2023-12-31: $18.35M2024-12-31: $2.30M2025-12-31: $5.87M$5.87M
2020-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$5.87M+154.7%2026-03-31, Balance as of period end
2024-12-31$2.30M-87.4%2026-03-31, Balance as of period end
2023-12-31$18.35M+20.4%2025-03-27, Balance as of period end
2022-12-31$15.24M-42.1%2024-03-28, Balance as of period end
2021-12-31$26.33Mn/m2023-07-24, Balance as of period end
2020-12-31-$51.82Mn/a2022-03-24, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Femasys Inc (FEMY)2025-12-31$5.87M+154.7%
QHSLab, Inc. (USAQ)2025-12-31$1.62Mn/m
Vycor Medical Inc (VYCO)2025-12-31-$4.09Mn/m
OSR Health, Inc. (OSRH)2025-12-31$127.04M-11.3%
EBR Systems, Inc. (NONE.)2025-12-31$25.59M+5.1%
Nuo Therapeutics, Inc. (AURX)2025-12-31-$956.6Kn/m
IceCure Medical Ltd. (ICCM)2025-12-31$9.05M+31.2%
Tenon Medical, Inc. (TNON)2025-12-31$5.04M-15.6%
Intelligent Bio Solutions Inc. (INBS)2026-06-30$5.51M+83.9%

Compare FEMY, USAQ, VYCO, OSRH side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗